National Planning Corporation’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

National Planning Corporation’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,500	Closed	-$583K	–	735
2016 Q4	$583K	Sell	24,500 -6,000	-20%	-$72.3K	0.05%	337
2016 Q3	$293K	Sell	30,500 -1,000	-3%	-$10K	0.02%	488
2016 Q2	$306K	Hold	31,500	–	–	0.02%	495
2016 Q1	$220K	Hold	31,500	–	–	0.02%	560
2015 Q4	$160K	Hold	31,500	–	–	0.01%	664
2015 Q3	$225K	Hold	31,500	–	–	0.02%	527
2015 Q2	$236K	Hold	31,500	–	–	0.02%	535
2015 Q1	$283K	Sell	31,500 -2,000	-6%	-$14.8K	0.03%	507
2014 Q4	$229K	Buy	33,500 +2,500	+8%	+$15.6K	0.02%	621
2014 Q3	$178K	Buy	+31,000	New	+$181K	0.01%	681

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

National Planning Corporation's ARIA Position: Q1 2017 in Review

National Planning Corporation sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 24,500 shares — an estimated $583K sold.

National Planning Corporation first reported a position in ARIA in Q3 2014 and held it in 10 quarters. The position peaked at $583K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

National Planning Corporation reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
National Planning Corporation sold 24,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $583K.
National Planning Corporation first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
National Planning Corporation's Ariad Pharmaceuticals Inc position peaked at $583K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on National Planning Corporation's 13F filing for Q1 2017, filed 15 May 2017.